ENTO

Entero Therapeutics

11 hedge funds and large institutions have $2.49M invested in Entero Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
PA
1
Perceptive Advisors
New York
$916K 227,272
PCM
2
Parsons Capital Management
Rhode Island
$745K 185,343 +101,525 +121%
JGC
3
J. Goldman & Co
New York
$328K 81,493 +81,493 New
SM
4
Sabby Management
Florida
$161K 40,000 -79,693 -67%
AAP
5
Ardsley Advisory Partners
Connecticut
$141K 35,000 +35,000 New
Millennium Management
6
Millennium Management
New York
$69K 17,227 +17,227 New
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$57K 14,247
BlackRock
8
BlackRock
New York
$57K 14,222 +14,222 New
UBS Group
9
UBS Group
Switzerland
$11K 2,769 -277 -9%
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$6K 1,500 +1,500 New
IWM
11
IHT Wealth Management
Illinois
$486 3,498 +464 +15%